ASP Isotopes (NASDAQ:ASPI) CFO Heather Kiessling Sells 23,124 Shares

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 23,124 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $6.28, for a total transaction of $145,218.72. Following the completion of the sale, the chief financial officer directly owned 1,526,252 shares in the company, valued at $9,584,862.56. This trade represents a 1.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Heather Kiessling also recently made the following trade(s):

• On Wednesday, April 15th, Heather Kiessling sold 23,124 shares of ASP Isotopes stock. The shares were sold at an average price of $5.48, for a total transaction of $126,719.52.

ASP Isotopes Trading Down 8.8%

ASPI opened at $5.63 on Friday. The business has a fifty day simple moving average of $6.25 and a 200-day simple moving average of $5.90. ASP Isotopes Inc. has a 52 week low of $3.92 and a 52 week high of $14.49. The firm has a market cap of $708.82 million, a P/E ratio of -2.71 and a beta of 3.51. The company has a quick ratio of 4.37, a current ratio of 4.39 and a debt-to-equity ratio of 0.69.

ASP Isotopes (NASDAQ:ASPI) last released its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.06. The company had revenue of $8.36 million during the quarter, compared to the consensus estimate of $3.68 million. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.

Institutional Trading of ASP Isotopes

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Encompass Capital Advisors LLC acquired a new stake in shares of ASP Isotopes during the 1st quarter worth about $30,551,000. Alyeska Investment Group L.P. raised its position in shares of ASP Isotopes by 73.4% in the fourth quarter. Alyeska Investment Group L.P. now owns 4,895,546 shares of the company’s stock valued at $26,191,000 after buying an additional 2,072,851 shares during the last quarter. UBS Group AG raised its position in shares of ASP Isotopes by 150.3% in the fourth quarter. UBS Group AG now owns 2,406,457 shares of the company’s stock valued at $12,875,000 after buying an additional 1,445,165 shares during the last quarter. Marshall Wace LLP lifted its stake in shares of ASP Isotopes by 3,669.1% during the third quarter. Marshall Wace LLP now owns 1,279,121 shares of the company’s stock valued at $12,305,000 after buying an additional 1,245,184 shares during the period. Finally, Vanguard Group Inc. lifted its stake in shares of ASP Isotopes by 37.9% during the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock valued at $43,451,000 after buying an additional 1,241,024 shares during the period. Hedge funds and other institutional investors own 16.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Canaccord Genuity Group reiterated a “buy” rating and set a $11.00 target price on shares of ASP Isotopes in a research report on Tuesday, April 14th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, ASP Isotopes has an average rating of “Hold” and an average target price of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.